10 年
手机商铺
入驻年限:10 年
谢先生
北京 大兴区
细胞库 / 细胞培养、试剂、技术服务、抗体、ELISA 试剂盒
生产厂商 代理商 经销商
公司新闻/正文
1216 人阅读发布时间:2020-01-17 14:26
Quidel commenced operations in 1979 and launched its first products in 1984. Since that time, Quidel has expanded its product base through internal development and acquisition with a focus on increasing its research and development efforts to accelerate the rate of new product introductions. Our core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development, and molecular assay development. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (5) molecular diagnostic products including the world’s first FDA-cleared handheld molecular device, AmpliVue. Additional molecular and Sofia tests are currently in development or in clinical trials as part of a robust product pipeline.
Whether at our headquarters in San Diego, California, at our research and manufacturing operations in Ohio, Massachusetts, or in Germany, or through our Commercial organization around the world, Quidel is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare.
产品列表:
|
Quidel |
MicroVue CIC-C1q EIA |
A001 |
1 kit |
|
Quidel |
MicroVue CIC Raji Cell Replacement EIA |
A002 |
1 ki |
|
Quidel |
MicroVue CIC-C1q Controls (Low and High Control) |
A013 |
1 ea. |
|
Quidel |
MicroVue CH50 Eq EIA |
A018 |
1 kit |
|
Quidel |
MicroVue Bb Plus Fragment EIA |
A027 |
1 kit |
|
Quidel |
MicroVue C1 Inhibitor Plus EIA |
A037 |
1 kit |
|
Quidel |
MicroVue iC3b Fragment EIA – For Research Use Only |
A006 |
1 kit |
|
Quidel |
MicroVue SC5b-9 Plus EIA – For Research Use Only |
A020 |
1 kit |
|
Quidel |
MicroVue C5a EIA – For Research Use Only |
A021 |
1 kit |
|
Quidel |
MicroVue C3a Plus EIA – For Research Use Only |
A031 |
1 kit |
|
Quidel |
MicroVue Ba Fragment EIA – For Research Use Only |
A033 |
1 kit |
|
Quidel |
MicroVue C4a EIA – For Research Use Only |
A035 |
1 kit |
|
Quidel |
MicroVue Animal Pan-Specific C3 Reagent Kit |
20261 |
1 kit |
|
Quidel |
Prekallikrein Activator (PKA) Assay Kit |
PW30100 |
1 kit |
|
Quidel |
Prekallikrein Activator (PKA) EP Assay Kit |
PW301EP |
1 kit |
|
Quidel |
Prekallikrein Activator (PKA) Ig Assay Kit |
PW30200 |
1 kit |
|
Quidel |
Prekallikrein Activator (PKA) Ig EP Assay Kit |
PW302EP |
1 kit |
|
Quidel |
Just Positive PKA Control |
PW51005 |
5x0.5 mL |
|
Quidel |
High Positive PKA Control |
PW52005 |
5x0.5 mL |
|
Quidel |
Anti-human C9 |
A223 |
100 µL |
|
Quidel |
Anti-human Factor B (Ba) |
A225 |
100 µL |
|
Quidel |
Anti-human Factor B (Bb) |
A227 |
100 µL |
|
Quidel |
Anti-human Factor H #1 |
A229 |
100 µL |
|
Quidel |
Anti-human Factor I #2 |
A231 |
100 µL |
|
Quidel |
Anti-human Factor P #1 |
A233 |
100 µL |
|
Quidel |
Anti-human Factor P #2 |
A235 |
100 µL |
|
Quidel |
Anti-human S Protein (vitronectin) |
A237 |
100 µL |
|
Quidel |
Anti-human SC5b-9 (TCC, neoantigen) |
A239 |
100 µL |
|
Quidel |
Anti-human Clusterin (SP40, 40 and Apo J) |
A241 |
100 µL |
|
Quidel |
Anti-human Factor I #1 |
A247 |
100 µL |
|
Quidel |
Anti-human C8 |
A249 |
100 µL |
|
Quidel |
Anti-human C3d (neoantigen) |
A250 |
100 µL |
|
Quidel |
Anti-human C4d (neoantigen) |
A251 |
100 µL |
|
Quidel |
Anti-human Bb (neoantigen) |
A252 |
100 µL |
|
Quidel |
Anti-human C4 (C4d) |
A253 |
0.5 mL |
|
Quidel |
Anti-human Factor H #2 |
A254 |
100 µL |
|
Quidel |
Anti-human Factor H #3 |
A255 |
100 µL |